FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2133404602> ?p ?o ?g. }

• W2133404602 abstract "Many studies have attempted to determine the best anaesthetic technique for neurosurgical procedures in patients without intracranial hypertension. So far, no study comparing intravenous (IA) with volatile-based neuroanaesthesia (VA) has been able to demonstrate major outcome differences nor a superiority of one of the two strategies in patients undergoing elective supratentorial neurosurgery. Therefore, current practice varies and includes the use of either volatile or intravenous anaesthetics in addition to narcotics. Actually the choice of the anaestesiological strategy depends only on the anaesthetists' preferences or institutional policies. This trial, named NeuroMorfeo, aims to assess the equivalence between volatile and intravenous anaesthetics for neurosurgical procedures. NeuroMorfeo is a multicenter, randomized, open label, controlled trial, based on an equivalence design. Patients aged between 18 and 75 years, scheduled for elective craniotomy for supratentorial lesion without signs of intracranial hypertension, in good physical state (ASA I-III) and Glasgow Coma Scale (GCS) equal to 15, are randomly assigned to one of three anaesthesiological strategies (two VA arms, sevoflurane + fentanyl or sevoflurane + remifentanil, and one IA, propofol + remifentanil). The equivalence between intravenous and volatile-based neuroanaesthesia will be evaluated by comparing the intervals required to reach, after anaesthesia discontinuation, a modified Aldrete score ≥ 9 (primary end-point). Two statistical comparisons have been planned: 1) sevoflurane + fentanyl vs. propofol + remifentanil; 2) sevoflurane + remifentanil vs. propofol + remifentanil. Secondary end-points include: an assessment of neurovegetative stress based on (a) measurement of urinary catecholamines and plasma and urinary cortisol and (b) estimate of sympathetic/parasympathetic balance by power spectrum analyses of electrocardiographic tracings recorded during anaesthesia; intraoperative adverse events; evaluation of surgical field; postoperative adverse events; patient's satisfaction and analysis of costs. 411 patients will be recruited in 14 Italian centers during an 18-month period. We presented the development phase of this anaesthesiological on-going trial. The recruitment started December 4th, 2007 and up to 4th, December 2008, 314 patients have been enrolled." @default.
• W2133404602 created "2016-06-24" @default.
• W2133404602 creator A5027518592 @default.
• W2133404602 creator A5029089981 @default.
• W2133404602 creator A5048772500 @default.
• W2133404602 creator A5061915173 @default.
• W2133404602 creator A5068298602 @default.
• W2133404602 creator A5088222616 @default.
• W2133404602 creator A5088399069 @default.
• W2133404602 date "2009-04-06" @default.
• W2133404602 modified "2023-09-23" @default.
• W2133404602 title "Anaesthesiological strategies in elective craniotomy: randomized, equivalence, open trial – The NeuroMorfeo trial" @default.
• W2133404602 cites W1483817731 @default.
• W2133404602 cites W1965748107 @default.
• W2133404602 cites W1977614469 @default.
• W2133404602 cites W1980573110 @default.
• W2133404602 cites W1986621959 @default.
• W2133404602 cites W2004631881 @default.
• W2133404602 cites W2006042048 @default.
• W2133404602 cites W2014948750 @default.
• W2133404602 cites W2021324541 @default.
• W2133404602 cites W2023594497 @default.
• W2133404602 cites W2038164622 @default.
• W2133404602 cites W2048718542 @default.
• W2133404602 cites W2051715620 @default.
• W2133404602 cites W2059848762 @default.
• W2133404602 cites W2059963622 @default.
• W2133404602 cites W2064429916 @default.
• W2133404602 cites W2067045085 @default.
• W2133404602 cites W2068852988 @default.
• W2133404602 cites W2068929370 @default.
• W2133404602 cites W2073906998 @default.
• W2133404602 cites W2087862329 @default.
• W2133404602 cites W2116775674 @default.
• W2133404602 cites W2142812371 @default.
• W2133404602 cites W2144446077 @default.
• W2133404602 cites W2159733957 @default.
• W2133404602 cites W2164963279 @default.
• W2133404602 cites W2166797988 @default.
• W2133404602 cites W2186657631 @default.
• W2133404602 doi "https://doi.org/10.1186/1745-6215-10-19" @default.
• W2133404602 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2673222" @default.
• W2133404602 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19348675" @default.
• W2133404602 hasPublicationYear "2009" @default.
• W2133404602 type Work @default.
• W2133404602 sameAs 2133404602 @default.
• W2133404602 citedByCount "16" @default.
• W2133404602 countsByYear W21334046022012 @default.
• W2133404602 countsByYear W21334046022013 @default.
• W2133404602 countsByYear W21334046022014 @default.
• W2133404602 countsByYear W21334046022015 @default.
• W2133404602 countsByYear W21334046022016 @default.
• W2133404602 countsByYear W21334046022017 @default.
• W2133404602 countsByYear W21334046022019 @default.
• W2133404602 countsByYear W21334046022021 @default.
• W2133404602 crossrefType "journal-article" @default.
• W2133404602 hasAuthorship W2133404602A5027518592 @default.
• W2133404602 hasAuthorship W2133404602A5029089981 @default.
• W2133404602 hasAuthorship W2133404602A5048772500 @default.
• W2133404602 hasAuthorship W2133404602A5061915173 @default.
• W2133404602 hasAuthorship W2133404602A5068298602 @default.
• W2133404602 hasAuthorship W2133404602A5088222616 @default.
• W2133404602 hasAuthorship W2133404602A5088399069 @default.
• W2133404602 hasBestOaLocation W21334046021 @default.
• W2133404602 hasConcept C141071460 @default.
• W2133404602 hasConcept C168563851 @default.
• W2133404602 hasConcept C2776277131 @default.
• W2133404602 hasConcept C2778891214 @default.
• W2133404602 hasConcept C2781072394 @default.
• W2133404602 hasConcept C2781312054 @default.
• W2133404602 hasConcept C2781453256 @default.
• W2133404602 hasConcept C42219234 @default.
• W2133404602 hasConcept C71924100 @default.
• W2133404602 hasConceptScore W2133404602C141071460 @default.
• W2133404602 hasConceptScore W2133404602C168563851 @default.
• W2133404602 hasConceptScore W2133404602C2776277131 @default.
• W2133404602 hasConceptScore W2133404602C2778891214 @default.
• W2133404602 hasConceptScore W2133404602C2781072394 @default.
• W2133404602 hasConceptScore W2133404602C2781312054 @default.
• W2133404602 hasConceptScore W2133404602C2781453256 @default.
• W2133404602 hasConceptScore W2133404602C42219234 @default.
• W2133404602 hasConceptScore W2133404602C71924100 @default.
• W2133404602 hasIssue "1" @default.
• W2133404602 hasLocation W21334046021 @default.
• W2133404602 hasLocation W21334046022 @default.
• W2133404602 hasLocation W21334046023 @default.
• W2133404602 hasLocation W21334046024 @default.
• W2133404602 hasLocation W21334046025 @default.
• W2133404602 hasLocation W21334046026 @default.
• W2133404602 hasOpenAccess W2133404602 @default.
• W2133404602 hasPrimaryLocation W21334046021 @default.
• W2133404602 hasRelatedWork W1488705246 @default.
• W2133404602 hasRelatedWork W1987437717 @default.
• W2133404602 hasRelatedWork W2130155811 @default.
• W2133404602 hasRelatedWork W2443816475 @default.
• W2133404602 hasRelatedWork W3031999943 @default.
• W2133404602 hasRelatedWork W3086199463 @default.
• W2133404602 hasRelatedWork W342924537 @default.
• W2133404602 hasRelatedWork W4386564657 @default.
• W2133404602 hasRelatedWork W2182523270 @default.

• next